Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Jul 06,2018
Artificial Bimolecular Networks Open Door to Sophisticated Diagnostic Testing
Scientists at Caltech say they have developed an artificial neural network made out of DNA that can solve a basic machine learning problem: correctly identifying handwritten numbers.
More
Artificial Bimolecular Networks Open Door to Sophisticated Diagnostic Testing
Jul 05,2018
Stem Cells Renew Heart Function in Primates with Cardiac Failure
Researchers at the University of Washington, Seattle, have used human embryonic stem cell-derived cardiomyocytes (hESC-CMs) to restore heart function in macaque monkeys with heart failure. The researchers hope that their achievement could pave the way for development of a similar treatment for human patients. The macaque studies showed that the transplanted hESC-CMs developed into ventricularRead more
More
Jul 05,2018
Biological Switch Can Control Genome Editing
A biological switch that reliably turns protein expression on at will have been invented by University of Bath and Cardiff University scientists. The switch enables control of genome editing tools that might one day regulate cascades of desired genetic changes through entire populations. The team points out that this new switching method should work for anyRead more
More
Jul 03,2018
Computing Method Used to Track Cancer Spread
Tracing and predicting the course that metastatic cancers take through the body may shed light on cellular changes that lead to metastasis. Metastatic disease causes about 90% of cancer deaths from solid tumors – masses of cells that grow in organs such as the breast, prostate, or colon. Understanding the drivers of metastasis could leadRead more
More
Computing Method Used to Track Cancer Spread
Jul 03,2018
Autism Genetic Complexity Comes to Light
Genes located in a large chromosomal aberration associated with autism interact with each other to modulate the variable symptoms of the disease, according to new research.  A Penn State-led team tested the role of these genes individually and in tandem by reducing the amount of the genes expressed in a fruit fly model.   TheirRead more
More
Jul 02,2018
Approved Anti-Cancer Drugs Reveal New Target: Non-Coding RNAs
Scientists at The Scripps Research Institute and the California Institute for Biomedical Research (CALIBR) have found that some types of small-molecule drugs, including marketed anticancer drugs, may work in part by binding to disease-related noncoding RNAs. Their discovery could open up new avenues of research for developing small-molecule drugs against what are otherwise considered undruggable.
More
Approved Anti-Cancer Drugs Reveal New Target: Non-Coding RNAs
Jul 02,2018
Alzheimer's Drugs Targeting Tau May Actually Exacerbate Disease
A new study by researchers from Drexel University College of Medicine reverses the popular scientific dogma that the protein tau stabilizes microtubules within brain cells. Their work ("Tau Does Not Stabilize Axonal Microtubules but Rather Enables Them to Have Long Labile Domains”), which appears in Current Biology, suggests just the opposite. Tau's actual role in theRead more
More
Alzheimer's Drugs Targeting Tau May Actually Exacerbate Disease
Jun 29,2018
Key Protein Mediating Inflammatory Response Discovered
Inflammation has always been a double-edged sword, providing critical action that helps heal wounds or thwart infections, in addition to damaging healthy cells and tissues due to a disproportionate response. Understanding the regulatory mechanisms that control the balance between positive and negative inflammation could open new drug discovery avenues for a variety of diseases andRead more
More
Key Protein Mediating Inflammatory Response Discovered
Jun 29,2018
Prostate Cancer Treatment Response Activated by Skin Disease Immunotherapy
Scientists in the U.K., Switzerland, and Italy have shown how a type of immunotherapy that is undergoing trials for treating psoriasis also renders advanced prostate cancer responsive to hormone therapy. The researchers' studies in human tissue and in a mouse model found that castration-resistant prostate cancer (CRCP) is driven by interleukin-23 (IL-23) produced by immuneRead more
More
Prostate Cancer Treatment Response Activated by Skin Disease Immunotherapy
Jun 28,2018
Cancer Cells Resist Dying through Telomerase Regulation
Cancer becomes more common as people get older, but scientists are still searching for answers about why this happens.  However now, investigators at the Hollings Cancer Center, part of the Medical University of South Carolina, found that human lung cancer cells resist dying by controlling parts of the aging process. Findings from the new studyRead more
More
Cancer Cells Resist Dying through Telomerase Regulation
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->